PropertyValue
?:abstract
  • The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is centralizing the interest of the scientific world. In the next months, long-term consequences on the endocrine system may arise following COVID-19. In this article, we hypothesized the effects of SARS-CoV-2 taking into account what learned from the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS in 2003.
?:creator
?:doi
  • 10.1007/s12020-020-02349-7
?:doi
?:journal
  • Endocrine
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/49d74c7c30346dcea0630814988b47d03136e346.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7266418.xml.json
?:pmcid
?:pmid
?:pmid
  • 32488837.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model
?:type
?:year
  • 2020-06-02

Metadata

Anon_0  
expand all